Rare diseases
Investigational molecules
Locations
1000 1st Avenue Suite 300, 19406-1333, United States
Vifor Pharma Inc. focuses on clinical research in hyperkalemia, with particular attention to the management of elevated blood potassium levels in pediatric populations. The sponsor’s funded trial activity centers on treatment approaches for children under 12 years of age affected by abnormal potassium balance.
Its current research interest is concentrated on care for young patients requiring control of clinically significant serum potassium elevation.
Vifor Pharma Inc. runs clinical trials in conditions such as Hyperkalaemia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
